Phase 2 Trial of Combination Radiotherapy and Pembrolizumab Plus Chemotherapy in Patients With Previously Untreated Metastatic NSCLC: NJLCG 1902

Introduction: Treatment strategies that enhance the efficacy of immunotherapy are desired. Radiotherapy can enhance immunity, but the utility of adding radiotherapy to immunotherapy plus platinum-doubled chemotherapy in patients with metastatic NSCLC has not been explored. Methods: This multicenter,...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yoko Tsukita, MD, PhD, Rei Umezawa, MD, PhD, Taku Nakagawa, MD, PhD, Akira Anbai, MD, PhD, Tomonori Makiguchi, MD, PhD, Hisashi Tanaka, MD, PhD, Yosuke Horii, MD, PhD, Aya Suzuki, MD, Ryo Morita, MD, PhD, Hitomi Nogawa, MD, Hiroshi Yokouchi, MD, PhD, Nozomu Kimura, MD, PhD, Keiichi Jingu, MD, PhD, Akira Inoue, MD, PhD, Hisatoshi Sugiura, MD, PhD, Eisaku Miyauchi, MD, PhD
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2025-05-01
Edice:	JTO Clinical and Research Reports
Témata:	NSCLC Radiotherapy Abscopal Pembrolizumab Chemotherapy
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2666364325000335
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!